Welcome to our dedicated page for Elite Hlth Sys SEC filings (Ticker: EHSI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Elite Health Systems Inc. (EHSI) provides detailed information about its governance, capital structure and transactions through SEC filings such as Forms 8-K and definitive proxy statements on Schedule 14A. These documents explain how the company conducts Special Meetings of Stockholders, what proposals are submitted for a vote, and how stockholders participate through virtual meetings and electronic proxy voting.
In its definitive proxy statement, Elite Health Systems Inc. outlines proposals including the election of five directors, an amendment to the Certificate of Incorporation to increase authorized common stock from 25,000,000 to 50,000,000 shares, approval of a 2025 Equity Incentive Plan with up to 4,500,000 shares, approval of the acquisition of Physician Support Systems, Inc. via a Share Exchange Agreement, ratification of Mercurius & Associates LLP as independent auditors, and authorization to adjourn the meeting if necessary. The proxy statement also describes voting standards, quorum requirements, and the treatment of broker non-votes.
A related Form 8-K reports both the entry into the Share Exchange Agreement with Physician Support Systems, Inc. and the voting results from the Special Meeting of Stockholders. It details the number of votes cast for, against and abstaining on each proposal, confirming stockholder approval of the director slate, authorized share increase, 2025 Equity Incentive Plan, PSS acquisition share issuance, auditor ratification, and adjournment authority. Another Form 8-K describes the conditions that must be satisfied before the PSS transaction can close, including stockholder approvals and the issuance of shares.
On this page, users can access Elite Health Systems Inc.’s SEC filings to review these disclosures directly. The platform can surface real-time updates from EDGAR, highlight key elements of 10-K, 10-Q or 8-K filings when available, and make it easier to locate information on stockholder proposals, equity compensation plans, material agreements, and auditor ratifications. Filings related to insider transactions on Form 4, when filed, can also be monitored to track changes in ownership by directors and officers.
Elite Health Systems Inc. insider report: CEO, director and 10% owner Prasad A. Jeereddi reported indirect purchases of Elite Health Systems Inc. common stock. On January 6, 2026, an entity of which he is a managing member and major equity owner acquired 400 shares of common stock at $1.33 per share. On January 8, 2026, the same entity acquired an additional 3,202 shares at $1.43 per share. Following these transactions, this entity held 225,716 indirectly owned shares, while Jeereddi also reported a separate directly held position of 3,356,663 shares of common stock.
Elite Health Systems Inc. received a new Schedule 13D reporting significant insider ownership following its acquisition of Physician Support Systems, Inc. The filing shows that CEO Prasad A. Jeereddi beneficially owns 3,578,777 shares of common stock, or approximately 12.69% of the company, including 222,114 shares held through an entity where he is a managing member and major shareholder. Praveena Jeereddi, his daughter and a practicing physician, beneficially owns 1,424,520 shares, or approximately 5.05%, including 35,000 shares held by a family trust.
The filing states that the most recent share acquisitions for both reporting persons occurred in connection with Elite Health Systems’ acquisition of Physician Support Systems, Inc., where they were the principal holders. As of November 4, 2025, the company had 28,200,424 shares of common stock outstanding. The reporting persons state there is no arrangement between them regarding voting or disposition of their shares and that they have no contracts or other relationships concerning the issuer’s securities.
Elite Health Systems Inc. (EHSI) reported a wider quarterly loss as it builds its Medicare Advantage platform. For Q3 2025, the company recorded no revenue and a net loss of $1,161,000 versus $290,000 a year ago, driven by higher selling, general and administrative expenses of $1,165,000 (up from $387,000).
Cash and cash equivalents were $3,970,000, total stockholders’ equity was $5,020,000, and 21,939,924 common shares were outstanding as of October 31, 2025. Year‑to‑date, the net loss was $2,026,000 versus $1,034,000 in 2024. The company raised $5,825,000 earlier in 2025 and an additional $1,890,000 by September 30, 2025 at $0.95 per share, exceeding $3,000,000 by the filing date.
Elite Health received a Knox‑Keene license in May 2025 and CMS conditional approval in June 2025, began marketing in October 2025, and plans to begin providing services on January 1, 2026. Stockholders approved issuing 3,158,000 shares to acquire Physician Support Systems, Inc., which closed November 1, 2025. The filing notes substantial doubt about going concern at September 30, 2025, though management cites recent financings and plans to continue operations.
Elite Health Systems Inc. reported the results of a Special Meeting of Stockholders held on September 26, 2025. A total of 21,939,924 common shares were eligible to vote, and 14,688,791 votes were cast, establishing a quorum.
Stockholders voted on director nominees and additional proposals. Director vote totals disclosed include: Dr. Prasad Jeereddi with 14,632,106 votes for and 56,685 against; Alan Gold with 14,633,106 for and 55,685 against; William Leimkuhler with 14,633,106 for and 55,685 against; William St. Lawrence with 14,633,106 for and 55,685 against; and Dr. Haranath Policherla with 14,688,791 for, 0 against, and 0 abstentions.
The filing also lists proposal vote counts as follows: 14,487,901 for and 200,890 against; 14,497,016 for and 191,775 against; 14,031,106 for, 157,685 against, and 500,000 abstentions; 14,688,791 for, 0 against, and 0 abstentions; and 14,622,906 for and 65,885 against.
Elite Health Systems Inc. discloses an acquisition agreement involving its Chief Executive Officer, Dr. Prasad Anjaneya Jeereddi, and his daughter, Dr. Praveena Jeereddi, identified as the selling stockholders. The filing states Dr. Jeereddi served as a principal executive officer from July 2024 through the end of that year and that PEO compensation reflects the amounts shown in the Summary Compensation Table for Alan Gold and Dr. Jeereddi. The proxy references an Annex A that contains the Acquisition Agreement terms and urges readers to review that document in full because the summary may omit material contract details. The filing also lists plan governance topics such as eligibility and award limits, terms for options, SARs and stock awards, performance award agreements, change of control provisions, compliance with securities laws, and tax withholding.
Elite Health Systems Inc. entered into a Share Exchange Agreement to acquire 100% of Physician Support Systems, Inc. (“PSS”) from its stockholders. As consideration, Elite Health Systems will issue 3,158,000 shares of its common stock to the PSS selling stockholders.
The transaction involves related parties, as Chief Executive Officer Dr. Prasad Jeereddi owns 46% of PSS and his daughter, Dr. Praveena Jeereddi, owns 44%. The deal is not yet closed and is contingent on stockholder approval of the Exchange Agreement, an amendment to increase authorized common shares, and satisfaction of specified closing conditions and deliverables.